在帕金森病中,突触内细胞流通的功能障碍在帕金森病中
1Programme in Neuroscience and Behavioural Disorders, Duke-NUS Medical School, Singapore, Singapore.
Neural regeneration research
|April 10, 2024
概括
受损的突触囊泡循环,特别是克拉中介的内细胞分裂,与帕金森病 (PD) 的发病有关. 了解这些内细胞缺陷可能会揭示PD的新治疗点.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 遗传学 是一个遗传学.
背景情况:
- 帕金森病 (PD) 涉及选择性多巴胺神经元退化,但原因尚不清楚.
- 遗传研究将PD与20多个PARK基因和90个风险位点联系起来.
- 许多已识别的基因都参与了突触囊泡的循环,特别是克拉斯林介导的内细胞分裂.
研究的目的:
- 审查PD相关的内细胞蛋白的细胞和分子发现.
- 探索克拉斯林介导的内细胞分裂在PD病变发生中的作用.
- 讨论与PD中的突触功能障碍相关的潜在治疗点.
主要方法:
- 从PD相关基因模型 (auxilin,synaptojanin 1) 中对细胞和分子发现的审查.
- 对全基因组关联研究的分析,确定内细胞通路中的PD风险因素.
- 探索PD相关的常见蛋白质 (α-synuclein,Parkin,LRRK2) 在突触内细胞贩运中的作用.
主要成果:
- 在奥克林 (DNAJC6/PARK19) 和synaptojanin 1 (SYNJ1/PARK20) 中发生突变的模型显示了类似的多巴胺终端病理.
- 这些模型在突触膜贩运中表现出缺陷,支持遗传发现.
- 几种克拉特林介导的内细胞酶蛋白和常见的PD相关蛋白质都与PD病变发生和突触内细胞贩运有关.
结论:
- 通过克拉特林介导的内细胞分解,突触囊泡循环的损伤可能是PD的早期特征.
- 内细胞通路和突触运输的功能障碍有助于PD的发病.
- 了解这些机制可能会揭示早期PD诊断和治疗的新目标.
更多相关视频
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.6K
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
5.9K
相关概念视频
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Excitatory and Inhibitory Effects of Neurotransmitters
9.9K
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of...
9.9K
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
